Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Aspartyl Adenylate
1. 19046-78-7
2. Aspartyl Adenylate
3. Succinyl Amp
4. Adenylosuccinate
5. X1b4zj0iiv
6. Succinyladenosine 5'-monophosphate
7. N6-(1,2-dicarboxyethyl)-amp
8. L-aspartic Acid, N-[9-(5-o-phosphono-beta-d-ribofuranosyl)-9h-purin-6-yl]-
9. 2-[9-(3,4-dihydroxy-5-phosphonooxymethyl-tetrahydro-furan-2-yl)-9h-purin-6-ylamino]-succinic Acid
10. Succinyladenosine Monophosphoric Acid
11. L-aspartic Acid, N-(9-(5-o-phosphono-beta-d-ribofuranosyl)-9h-purin-6-yl)-
12. N(6)-(1,2-dicarboxyethyl)amp
13. 2sa
14. Adenyl-succinic Acid
15. 6-succino-5'-adenylate
16. Unii-x1b4zj0iiv
17. 6-succino-5'-adenylic Acid
18. Schembl198136
19. N6-(1,2-dicarboxyethyl)amp
20. Succinyladenosine Monophosphorate
21. Dtxsid80864869
22. L-aspartic Acid, N-(9-(5-o-phosphono-.beta.-d-ribofuranosyl)-9h-purin-6-yl)-
23. D-ribofuranosyl)-9h-purin-6-yl]
24. Zinc4096207
25. Adenylosuccinic Acid, ~96% (hplc)
26. Db04418
27. (2s)-2-[[9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic Acid
28. Hy-127137
29. Cs-0093525
30. C03794
31. Q27095207
32. D-ribofuranosyl-9h-purin-6-yl) Mono(dihydrogen Phosphate) (ester)
33. N-(9-(5-o-phosphono-.beta.-d-ribofuranosyl)-9h-purin-6-yl)-l-aspartic Acid
34. (2s)-2-[(9-{(2r,3r,4s,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydrofuran-2-yl}-9h-purin-6-yl)amino]butanedioic Acid (non-preferred Name)
35. (2s)-2-[[9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(phosphonooxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]butanedioic Acid
36. (s)-2-((9-((2r,3r,4s,5r)-3,4-dihydroxy-5-((phosphonooxy)methyl)tetrahydrofuran-2-yl)-9h-purin-6-yl)amino)succinic Acid
37. (s)-2-((9-((2r,3r,4s,5r)-3,4-dihydroxy-5-((phosphonooxy)methyl)tetrahydrofuran-2-yl)-9h-purin-6-yl)amino)succinicacid
38. (s)-2-(9-((2r,3r,4s,5r)-3,4-dihydroxy-5-(phosphonooxymethyl)tetrahydrofuran-2-yl)-9h-purin-6-ylamino)succinic Acid
| Molecular Weight | 463.29 g/mol |
|---|---|
| Molecular Formula | C14H18N5O11P |
| XLogP3 | -3.2 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 9 |
| Exact Mass | 463.07404340 g/mol |
| Monoisotopic Mass | 463.07404340 g/mol |
| Topological Polar Surface Area | 247 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 725 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
78
PharmaCompass offers a list of Aspartyl Adenylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Aspartyl Adenylate manufacturer or Aspartyl Adenylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aspartyl Adenylate manufacturer or Aspartyl Adenylate supplier.
A adenylosuccinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of adenylosuccinate, including repackagers and relabelers. The FDA regulates adenylosuccinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. adenylosuccinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A adenylosuccinate supplier is an individual or a company that provides adenylosuccinate active pharmaceutical ingredient (API) or adenylosuccinate finished formulations upon request. The adenylosuccinate suppliers may include adenylosuccinate API manufacturers, exporters, distributors and traders.
click here to find a list of adenylosuccinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A adenylosuccinate DMF (Drug Master File) is a document detailing the whole manufacturing process of adenylosuccinate active pharmaceutical ingredient (API) in detail. Different forms of adenylosuccinate DMFs exist exist since differing nations have different regulations, such as adenylosuccinate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A adenylosuccinate DMF submitted to regulatory agencies in the US is known as a USDMF. adenylosuccinate USDMF includes data on adenylosuccinate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The adenylosuccinate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of adenylosuccinate suppliers with USDMF on PharmaCompass.
adenylosuccinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of adenylosuccinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right adenylosuccinate GMP manufacturer or adenylosuccinate GMP API supplier for your needs.
A adenylosuccinate CoA (Certificate of Analysis) is a formal document that attests to adenylosuccinate's compliance with adenylosuccinate specifications and serves as a tool for batch-level quality control.
adenylosuccinate CoA mostly includes findings from lab analyses of a specific batch. For each adenylosuccinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
adenylosuccinate may be tested according to a variety of international standards, such as European Pharmacopoeia (adenylosuccinate EP), adenylosuccinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (adenylosuccinate USP).
